Madhi SA - Search Results

1

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R. Siber GR, et al. Among authors: madhi sa. Vaccine. 2007 May 10;25(19):3816-26. doi: 10.1016/j.vaccine.2007.01.119. Epub 2007 Feb 21. Vaccine. 2007. PMID: 17368878

2

Emergence of drug resistance. Impact on bacterial meningitis.

Klugman KP, Madhi SA. Klugman KP, et al. Among authors: madhi sa. Infect Dis Clin North Am. 1999 Sep;13(3):637-46, vii. doi: 10.1016/s0891-5520(05)70098-2. Infect Dis Clin North Am. 1999. PMID: 10470559 Review.

3

Pneumococcal conjugate vaccine--prospects for intervention in children.

Madhi SA, Klugman KP. Madhi SA, et al. Semin Respir Infect. 1999 Sep;14(3):285-94. Semin Respir Infect. 1999. PMID: 10501316 Review. No abstract available.

4

Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children.

Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. Madhi SA, et al. Among authors: madhi a. Pediatr Infect Dis J. 2000 Dec;19(12):1141-7. doi: 10.1097/00006454-200012000-00004. Pediatr Infect Dis J. 2000. PMID: 11144373

5

Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection.

Madhi SA, Ramasamy N, Bessellar TG, Saloojee H, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2002 Apr;21(4):291-7. doi: 10.1097/00006454-200204000-00007. Pediatr Infect Dis J. 2002. PMID: 12075759

6

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.

Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, Saloojee H, Crewe-Brown H, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2002 Apr;21(4):315-21. doi: 10.1097/00006454-200204000-00011. Pediatr Infect Dis J. 2002. PMID: 12075763

7

Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children.

Madhi SA, Cumin E, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2002 May;21(5):393-9. doi: 10.1097/00006454-200205000-00009. Pediatr Infect Dis J. 2002. PMID: 12150175

8

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. Klugman KP, et al. Among authors: madhi sa. N Engl J Med. 2003 Oct 2;349(14):1341-8. doi: 10.1056/NEJMoa035060. N Engl J Med. 2003. PMID: 14523142 Free article. Clinical Trial.

9

Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants.

Madhi SA, Ludewick H, Abed Y, Klugman KP, Boivin G. Madhi SA, et al. Clin Infect Dis. 2003 Dec 15;37(12):1705-10. doi: 10.1086/379771. Epub 2003 Nov 19. Clin Infect Dis. 2003. PMID: 14689355 Free PMC article.

10

Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia.

Buie KA, Klugman KP, von Gottberg A, Perovic O, Karstaedt A, Crewe-Brown HH, Madhi SA, Feldman C. Buie KA, et al. Among authors: madhi sa. J Infect Dis. 2004 Jun 1;189(11):1996-2000. doi: 10.1086/386548. Epub 2004 May 12. J Infect Dis. 2004. PMID: 15143465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters